Technology
Cell Enrichment and Extraction™
Biocept has developed the Cell Enrichment and Extraction™ (CEE) technology, which utilizes the company’s proprietary system to capture rare cells in a microfluidic device.
Oncology
The CEE system has demonstrated that it can consistently capture extremely rare cells which may be present in only 1 of every 5-10 billion blood cells. Examples of these are circulating tumor cells (CTCs) in patients with early-stage, metastatic or recurrent cancer.
Life Sciences
Biocept has entered into collaborations with several academic institutions and pharmaceutical or biotech companies to explore the application of the CEE system to research involving particular cancers, drug or treatment therapies, or proprietary antibodies in development.
